Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Genetics Investing
Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene Biotech Investing
Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China Pharmaceutical Investing
Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies Genetics Investing
